Early first-line systemic anticancer therapeutic attrition after metastatic recurrence in triple-negative breast cancer following neoadjuvant chemo-immunotherapy: a multicenter real-world study
Breast Cancer Research and Treatment · 2026-07 · 218 (1)
DOI: 10.1007/s10549-026-08023-2 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 10.07.2026. Verfasst von Palma Fedele und 22 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Unit, Dario Camberlingo Hospital, 72021, Francavilla Fontana, Brindisi, Italy. palma.fedele@asl.brindisi.it. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Neoplasm Recurrence, Local, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oncology Unit, Dario Camberlingo Hospital, 72021, Francavilla Fontana, Brindisi, Italy. palma.fedele@asl.brindisi.it.
- S.S.D. C.O.r.O. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori "Giovanni Paolo II", 70124, Bari, Italy.
- U.O. Medical Oncology and Biomolecular Therapy, Department of Medical and Surgical Sciences, University of Foggia, 71100, Foggia, Italy.
- Breast Care Unit, University Hospital Consortium Policlinico of Bari, 70124, Bari, Italy.
- Oncology Unit, Fondazione "Casa Sollievo della Sofferenza", IRCCS, 71013, San Giovanni Rotondo, Foggia, Italy.
- Oncology Unit, San Paolo Hospital, 70123, Bari, Italy.
Zitieren
APA
Fedele, P., Rizzo, A., Landriscina, M., Stucci, L. S., Inneo, C., Morritti, M., Morelli, F., Giuliani, F., Moraca, L., Cairo, G., Giampaglia, M., Tedesco, B., Melaccio, A., Maselli, F. M., Gnoni, A., Licchetta, A., Fumai, F., Vitale, E., Marino, F. R., …, & Gadaleta-Caldarola, G. (2026). Early first-line systemic anticancer therapeutic attrition after metastatic recurrence in triple-negative breast cancer following neoadjuvant chemo-immunotherapy: a multicenter real-world study. Breast Cancer Research and Treatment, 218(1). https://doi.org/10.1007/s10549-026-08023-2
Vancouver
Fedele P, Rizzo A, Landriscina M, Stucci LS, Inneo C, Morritti M, et al. Early first-line systemic anticancer therapeutic attrition after metastatic recurrence in triple-negative breast cancer following neoadjuvant chemo-immunotherapy: a multicenter real-world study. Breast Cancer Research and Treatment. 2026;218(1). doi:10.1007/s10549-026-08023-2
BibTeX
@article{Fedele2026,
author = {Fedele, Palma and Rizzo, Alessandro and Landriscina, Matteo and Stucci, Luigia Stefania and Inneo, Carmela and Morritti, Maria and Morelli, Franco and Giuliani, Francesco and Moraca, Lucia and Cairo, Giuseppe and Giampaglia, Marianna and Tedesco, Beatrice and Melaccio, Assunta and Maselli, Felicia M and Gnoni, Antonio and Licchetta, Antonella and Fumai, Federica and Vitale, Elsa and Marino, Fiorella Restaino and Zifarone, Emanuela and Lanotte, Laura and Ardito, Raffaele and Gadaleta-Caldarola, Gennaro},
title = {Early first-line systemic anticancer therapeutic attrition after metastatic recurrence in triple-negative breast cancer following neoadjuvant chemo-immunotherapy: a multicenter real-world study},
journal = {Breast Cancer Research and Treatment},
year = {2026},
volume = {218},
number = {1},
doi = {10.1007/s10549-026-08023-2}
}
EUVIMED